180 Life Sciences Corp. (ATNF)

NASDAQ: ATNF · IEX Real-Time Price · USD

1.650

+0.150 (10.00%)

At close: Jul 2, 2024, 3:59 PM

1.540

-0.110 (-6.67%)

After-hours: Jul 2, 2024, 7:10 PM EDT

180 Life Sciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2017
Selling, General & Admin	10.69	15.47	11.69	3.36	5.89	Upgrade
Research & Development	2.78	2.43	3.95	2.29	2.04	Upgrade
Other Operating Expenses	0	0	0	0	12.93	Upgrade
Operating Expenses	13.48	17.9	15.64	5.65	20.86	Upgrade
Operating Income	-13.48	-17.9	-15.64	-5.65	-20.86	Upgrade
Interest Expense / Income	0.04	0.03	0.19	1.09	0.19	Upgrade
Other Expense / Income	8.76	21.74	4.52	4.17	4.36	Upgrade
Pretax Income	-22.28	-39.67	-20.35	-10.9	-25.4	Upgrade
Income Tax	-2.35	-0.94	-0.02	-0.02	-0.01	Upgrade
Net Income	-19.94	-38.73	-20.32	-10.88	-25.39	Upgrade
Preferred Dividends	0	0	0	1.12	0	Upgrade
Net Income Common	-19.94	-38.73	-20.32	-12.01	-25.39	Upgrade
Shares Outstanding (Basic)	0	0	0	0	0	Upgrade
Shares Outstanding (Diluted)	0	0	0	0	0	Upgrade
Shares Change	279.01%	21.22%	72.72%	64.51%	-25.83%	Upgrade
EPS (Basic)	-52.59	-387.18	-246.24	-250.80	-874.00	Upgrade
EPS (Diluted)	-52.59	-387.18	-246.24	-250.80	-874.00	Upgrade
Free Cash Flow	-10.92	-12.13	-19.37	-3.87	-3.32	Upgrade
Free Cash Flow Per Share	-28.81	-121.25	-234.76	-81.05	-114.28	Upgrade
EBITDA	-22.13	-39.53	-20.05	-9.69	-25.15	Upgrade
Depreciation & Amortization	0.11	0.11	0.11	0.13	0.07	Upgrade
EBIT	-22.24	-39.64	-20.16	-9.82	-25.22	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).